Uttarakhand News Today

Cushing’s Syndrome and Acromegaly Treatment Market expected to grow at a CAGR of 8.92% | Corcept Therapeutics, Ipsen Biopharmaceuticals, Inc., HRA Pharma

 Breaking News
  • No posts were found

Cushing’s Syndrome and Acromegaly Treatment Market expected to grow at a CAGR of 8.92% | Corcept Therapeutics, Ipsen Biopharmaceuticals, Inc., HRA Pharma

September 17
21:31 2020

Cushing’s Syndrome and Acromegaly Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025-  Increasing investment  in research and development for better healthcare treatments is anticipated to drive the growth of Global Cushing’s Syndrome and Acromegaly Treatment Market.

Get Sample Report: @ https://brandessenceresearch.com/requestSample/PostId/535

Cushing’s Syndrome and Acromegaly Treatment Market is expected to grow at a CAGR of 8.92% over the forecast period.

Market Analysis of Cushing’s Syndrome and Acromegaly Treatment-

Cushing syndrome occurs due to abnormally high levels of the hormone cortisol. It is all about the stress hormone cortisol. This condition, also known as hypercortisolism and affects about three times as many women as men. It’s most often seen in people ages 25 to 40. It occurs when body is exposed to high levels of the hormone cortisol for a long time. It may be caused by the use of oral corticosteroid medication. In this condition body makes too much of the hormone cortisol over a long period of time. It can cause health problems such as: heart attack and stroke, blood clots in the legs and lungs, infections, bone loss and fractures, high blood pressure, unhealthy cholesterol levels, depression or other mood changes, memory loss or trouble concentrating, insulin resistance and prediabetes and type 2 diabetes.

Acromegaly is a hormonal disorder that results from too much growth hormone in the body. In this condition, pituitary produces excessive amounts of growth hormone. Usually the excess GH comes from benign, or noncancerous, tumors on the pituitary. When this happens, bones increase in size, including those of patient’s hands, feet and face. It majorly affects middle-aged adults, though it can develop at any age. Increasing prevalence of Cushing’s Syndrome and Acromegaly and growing adoption of new methods of treatments are major factors driving the market growth.

Global cushing’s syndrome and acromegaly treatment market report is segmented on the basis of drug type, sales channel and region & country level. Based upon drug type, global cushing’s syndrome treatment is classified into somatostatin, glucocorticoid receptor inhibitors, ketoconazole hra and other off-label and acromegaly treatment is classified into glucocorticoid receptor inhibitors, somatostatin and other off-label. Based on sales channel, the cushing’s syndrome and acromegaly treatment market is classified into retail pharmacies, hospital pharmacies and online pharmacies.

The regions covered in this Cushing’s Syndrome and Acromegaly Treatment Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of Cushing’s Syndrome and Acromegaly Treatment is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Key Players

Some major key players for global cushing’s syndrome and acromegaly treatment market are Corcept Therapeutics, Ipsen Biopharmaceuticals, Inc., HRA Pharma, Novartis AG, Bristol-Myers Squibb Company, Pfizer Inc. and others.

Increasing Awareness, Increasing Investments in the Research and Development and Growing Adoption of New Treatments are the Major Factors Driving the Market Growth.

The major factors driving the growth of global cushing’s syndrome and acromegaly treatment market are the prevalence of  cushing’s syndrome and acromegaly and increasing government initiatives for the treatment of Cushing’s syndrome and Acromegaly. For example; American Association of Neurological Surgeons; An estimated 10-15 per million people are affected every year. Pituitary adenomas (Cushing’s disease) account for more than 70 percent of cases in adults and about 60-70 percent of cases in children and adolescents. Cushing’s syndrome most commonly affects adults ages 20-50 and is more prevalent in females, accounting for about 70 percent of all cases.

In addition, increased disposable income in the emerging economies and growing healthcare expenditure coupled with the rising adoption of non-invasive treatment are also accelerating the growth of global cushing’s syndrome and acromegaly treatment market. Furthermore, increasing government initiatives for the growth in awareness and development of healthcare infrastructure are also supplementing the market growth. Increasing research and development to develop more innovative and effective treatments for cushing’s syndrome and acromegaly is also fostering the market growth. Recently, several techniques have been developed to aid in the early identification and monitoring of acromegaly and its associated complications. These advances in disease identification have led to a rise in the number of patients diagnosed with the disease and the development of better treatment modalities. This, in turn, will result in increased cure and decreased mortality rates in acromegaly patients.

However, lack of awareness regarding the latest treatments in the underdeveloped economies and the high cost of drugs may hamper the market growth. Moreover, increasing technological advancements for more innovative and effective treatments can provide various opportunities for the further growth of global cushing’s syndrome and acromegaly treatment market.

North America is Expected to Dominate the Global Cushing’s Syndrome and Acromegaly Treatment Market

The global cushing’s syndrome and acromegaly treatment market is segmented into North America, Europe, Asia-Pacific Latin America and Middle East & Africa. North America is expected to dominate the global cushing’s syndrome and acromegaly treatment market within the forecast period attributed to  the highly developed healthcare infrastructure and availability highly advanced healthcare solutions in this region. Europe is projected to capture the second largest share of global cushing’s syndrome and acromegaly treatment market owing to the presence of leading players in this region. Asia Pacific is anticipated to witness a significant growth with a highest CAGR owing to the imroving healthcare infrastructure and increasing research and development for new and more effective treatments in this region.

Key Benefits for Market Report–

  • Global Cushing’s Syndrome and Acromegaly Treatment Market report covers in-depth historical and forecast analysis.
  • Global Cushing’s Syndrome and Acromegaly Treatment Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
  • Global Cushing’s Syndrome and Acromegaly Treatment Market report helps to identify opportunities in marketplace.
  • Global Cushing’s Syndrome and Acromegaly Treatment Market report covers extensive analysis of emerging trends and competitive landscape.

Market Segmentation:-

By Drug Type:

  • Cushing’s Syndrome Treatment
  • Somatostatin
  • Ketoconazole HRA
  • Glucocorticoid Receptor Inhibitors
  • Other Off-label
  • Acromegaly Treatment
  • Glucocorticoid Receptor Inhibitors
  • Somatostatin
  • Other Off-label

By Sales Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Regional & Country Level:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Get Full Report: @ https://brandessenceresearch.com/healthcare/cushing-s-syndrome-and-acromegaly-treatment-market-size

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at [email protected]

Media Contact
Company Name: Brandessence Market Research and Consulting Pvt ltd.
Contact Person: Alan
Email: Send Email
Phone: +917447409162
Address:Office No 101 City Point, Survey No. 171/9, Bhekrai Nagar, Near HP Petrol Pump, Opp. HDFC bank Hadapsar-Saswad Road
City: Pune
State: Maharashtra
Country: India
Website: https://brandessenceresearch.com/

Related Articles